Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Safety and Electrophysiological Study of Closed-loop Pudendal Neuromodulation Using an Implantable (Picostim-DyNeuMo) Device in Women With Urinary Incontinence

NCT05241379 is registered in ClinicalTrials.gov with Amber Therapeutics Ltd as lead sponsor.

NCT NCT05241379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Safety and Electrophysiological Study of Closed-loop Pudendal Neuromodulation Using an Implantable (Picostim-DyNeuMo) Device in Women With Urinary Incontinence
Lead sponsor
Amber Therapeutics Ltd
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2022
Completion date
April 15, 2024
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urge incontinence